{"url_path":"/sec/anf/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-05","source_url":"https://www.sec.gov/Archives/edgar/data/1018840/0001018840-26-000036-index.html","accession_number":"0001018840-26-000036","cik":"0001018840","ticker":"ANF","issuer_name":"ABERCROMBIE & FITCH CO /DE/","edgar_url":"https://www.sec.gov/Archives/edgar/data/1018840/0001018840-26-000036-index.html","primary_entity_key":"0001018840","primary_entity_name":"ABERCROMBIE & FITCH CO /DE/"},"word_count":153,"has_tables":true,"body_markdown":"Item 5. Other Information\n\nExcept as disclosed below, during the thirteen weeks ended May 2, 2026, no director or officer of the Company adopted a new “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” and no director or officer of the Company modified or terminated an existing “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K under the Exchange Act:\n\n•On March 6, 2026, Scott Lipesky, the Company’s Chief Operating Officer, adopted a trading plan intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr.Lipesky’s trading plan provides for the sale of up to 40,000 shares of Common Stock in amounts and prices determined in accordance with the trading plan’s terms and terminates on the earlier of: (i) the date on which all shares authorized for sale under the trading plan are sold or (ii) March 4, 2027."}